Bill of Health

AUGUST 29, 2022

2] E.g. , Racial Disproportionality and Disparity in Child Welfare , Dep’t Health & Hum. Bureau 1, 2 (2014); Robert B. Health Care Issues for Children and Adolescents in Foster Care and Kinship Care , 136 Pediatrics e1131, e1132 (2015). [6] Omicron Surge , Bloomberg (Dec. & Fams., 3] Bell, supra note 99 at 26. [4]

COVID-19 Vaccine 130

COVID-19 Vaccine COVID-19 Informed Consent Governance 130

SQA

MAY 24, 2023

The deadline for reporting serious incidents not constituting serious public health threats, deaths, or unanticipated serious deteriorations in state of health was reduced to 15 calendar days. PCPC’s current priority is to work with the FDA to effectively implement the Modernization of Cosmetics Regulation Act of 2022.

FDA 40

FDA Licensing Governance Compliance 40

SQA

OCTOBER 18, 2024

NPMA Issues Draft Guidelines for Inspection of Medical Device Clinical Trial Sites, 14 June 2024 China NMPA has released a new guideline that aims to enhance the management of clinical trial institutions for medical devices, ensuring compliance with regulatory standards and safeguarding public health.

FDA 52

FDA Compliance Public Health World Health 52

SQA

AUGUST 8, 2023

The rules also cover other services that perform activities related to clinical analysis examinations, such as isolated (private) offices and pharmacies, which are considered health services since the publication of Law 13.021/2014. cosmetic regulatory framework. Consumer and product safety remains at the heart of our industry.

FDA 40

FDA Compliance COVID-19 World Health 40

SQA

FEBRUARY 26, 2024

The glossary was originally published in 2014 and has been used to define excipient terms and acronyms commonly found in IPEC guides. PCPC provided feedback to the FDA on the development of an efficient electronic submission program (Cosmetics Direct) and recognizes that the FDA’s development of Cosmetics Direct is ongoing.

FDA 52

FDA Compliance COVID-19 Public Health 52

Kaiser Health News

JUNE 2, 2022

when the FDA approved mifepristone in 2000. Some legal and drug regulatory experts argue that because the FDA is the federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human drugs, states wouldn’t have the power to overrule its stamp of approval and outlaw the abortion pill.

FDA 93

FDA Public Health Governance 93

Drug & Device Law

FEBRUARY 29, 2024

Not to mention, it is a powerful defense for our clients in product liability matters because it can foreclose liability and plaintiffs’ use of tort lawsuits (invariably creatures of state law origin) to impose requirements on medical devices or pharmaceuticals that the federal FDA did not. What could be better than preemption? United Bhd.

COVID-19 59

COVID-19 Informed Consent FDA Governance 59

Drug & Device Law

DECEMBER 28, 2023

In addition, although we generally do not speak of judges, we note that the judge overseeing this MDL took the federal bench in 1994—a year after Daubert —and had a, shall we say, interesting history with issues of preemption and the FDA over the first year or so of the MDL. The facts and posture are fairly simple. 2023 WL 8711617, *2.

FDA 52

FDA World Health Public Health 52

Drug & Device Law

MARCH 2, 2023

Commentators beyond this Blog have described how this bent affects contraceptive choice and public health. In the same month in 2014, the Supreme Court issued the Bauman decision on general personal jurisdiction and the Walden case on specific personal jurisdiction.

FDA 59

FDA Public Health 59

Drug & Device Law

JUNE 28, 2022

Jackson Women’s Health Org. , June 24, 2022), we fully expect attempts by such states to ban FDA-approved prescription drugs that can be used to bring about abortions by chemical means. But when the FDA has approved a product, states no longer have the power to prohibit their sale or use for FDA-approved indications.

FDA 116

FDA Public Health Federal Policy Doctors 116